The Drug Annotations series was launched in 2014 to highlight newly approved drugs or clinical candidates that are likely to provide significant patient benefits over existing therapies. Watch Dr. Jeff Zablocki, Journal of Medicinal Chemistry Drug Annotations Editor from Gilead Sciences Inc. introduce the Drug Annotations series, describes its impact on the field and provides advice to authors interested in […]
The Drug Annotations series was launched in 2014 to highlight newly approved drugs or clinical candidates that are likely to provide significant patient benefits over existing therapies. Watch Dr. Jeff Zablocki, Journal of Medicinal Chemistry Drug Annotations Editor from Gilead Sciences Inc. introduce the Drug Annotations series, describes its impact on the field and provides advice to authors interested in contributing to the series.
